SCHEMBL7583147

SCHEMBL7583147

Cc1ccc(Nc2ncnn3cc(C(=O)O)c(C)c23)cc1NS(C)(=O)=O

nearest known ligand 0.58

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 14/20 0.58
KDR P35968 6/20 0.58
EGFR P00533 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4045059 0.90 KDR (0.72) MAPK14KDR
SCHEMBL27888123 0.89 EGFR (0.56) MAPK14KDREGFR
SCHEMBL5739243 0.86 KDR (0.60) MAPK14KDREGFR
SCHEMBL14451947 0.84 MAPK14 (0.51) MAPK14KDREGFR
SCHEMBL5516114 0.83 KDR (0.80) KDREGFR
SCHEMBL5740421 0.83 KDR (0.52) MAPK14KDREGFR
SCHEMBL4044821 0.83 MAPK14 (0.69) MAPK14KDR
SCHEMBL27582132 0.83 MAPK14 (0.59) MAPK14KDR
SCHEMBL4044344 0.81 EGFR (0.66) MAPK14KDREGFR
SCHEMBL7530745 0.81 KDR (0.70) MAPK14KDREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1622946-A Methods of treating conditions associated with p38 kinase and pyrrolotriazine compounds useful as kinase inhibitors BRISTOL MYERS SQUIBB CO (US) 2005-06-01 CN disclosed
EP-1183033-A4 PYRROLOTRIAZINE INHIBITORS OF KINASES BRISTOL MYERS SQUIBB CO (US) 2002-07-17 EP disclosed
EP-1183033-A1 PYRROLOTRIAZINE INHIBITORS OF KINASES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-03-06 EP disclosed
WO-2000071129-A1 PYRROLOTRIAZINE INHIBITORS OF KINASES BRISTOL-MYERS SQUIBB COMPANY (US) 2000-11-30 WO disclosed